A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice
A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Alzheimer's disease (AD) is the leading cause of dementia. Non-competitive N-Methyl-D-aspartate (NMDA) receptor antagonist memantine improved cognition and molecular alterations after preclinical treatment. Nevertheless, clinical results are discouraging. In vivo efficacy of the RL-208, a new NMDA receptor blocker described recently, with favourabl...
Alternative Titles
Full title
A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_506b5a2b20f3415e94f82e042797ec90
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_506b5a2b20f3415e94f82e042797ec90
Other Identifiers
ISSN
1999-4923
E-ISSN
1999-4923
DOI
10.3390/pharmaceutics12030284
